Update of PDE5 inhibitors for the treatment of ischemia-reperfusion / 中华男科学杂志
National Journal of Andrology
; (12): 842-846, 2011.
Article
em Zh
| WPRIM
| ID: wpr-305776
Biblioteca responsável:
WPRO
ABSTRACT
Phosphodiesterase type 5 (PDE5) inhibitors are used most commonly in the treatment of penile erectile dysfunction (ED). Recent studies show that PDE5 inhibitors are ideal drugs for treating ischemia-reperfusion injury. This review focuses on the results of basic and clinical researches on PDE5 inhibitors for the treatment of ischemia-reperfusion injury and provides some theoretical evidence for clinical options of the drugs.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Inibidores de Fosfodiesterase
/
Traumatismo por Reperfusão
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Inibidores da Fosfodiesterase 5
/
Disfunção Erétil
Limite:
Humans
/
Male
Idioma:
Zh
Revista:
National Journal of Andrology
Ano de publicação:
2011
Tipo de documento:
Article